[MYGN] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
24-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 14.91%
YoY- 1.55%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 189,400 93,200 215,400 200,900 200,500 186,500 189,900 -0.04%
PBT -3,800 -58,500 -7,700 16,100 18,800 37,300 35,500 -
Tax 900 -3,000 -3,400 3,000 6,100 13,900 16,800 -38.57%
NP -4,700 -55,400 -4,200 13,100 12,900 23,400 18,700 -
Tax Rate - - - -18.63% -32.45% -37.27% -47.32% -
Total Cost 194,100 148,600 219,600 187,800 187,600 163,100 171,200 2.11%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -2.48 -59.44 -1.95 6.52 6.43 12.55 9.85 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.06 -0.74 -0.06 0.19 0.19 0.33 0.27 -
EPS Diluted -0.06 -0.74 -0.06 0.18 0.19 0.32 0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.